Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 16 2014
Print

Rosa & Co. Acquires Entelos Service Business



By Kristin Brooks



Published January 23, 2014
Related Searches: Development
Rosa & Co. LLC, a drug development consulting firm, has acquired the consulting service business of Entelos Holdings, Inc., which conducts mechanistic, physiologic, in silico modeling projects for customers for pharmaceutical research and development. The acquisition expands Rosa's presence in quantitative systems pharmacology and modeling and simulation research services and adds expertise in cardiovascular, immunology, and metabolism biology, and human nutrition.
 
The acquisition also allows Entelos' clients to access Rosa's PhysioPD Research Platforms, which employ a user-friendly, open-architecture modeling and simulation system that is interoperable with commonly used third-party software.
 
"We are thrilled to further strengthen our expertise in these key areas, and have the opportunity to offer our proven approach to an expanded client base,” said chief executive officer of Rosa, Ron Beaver, Ph.D."


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On